'Medical writing encounters premature job shifts limiting skill maturity'

INDIA has emerged as a global hub for medical writing. However, this growth is tempered by persistent challenges including high attrition rates, premature job shifts limiting skill maturity, risks of overreliance and misuse of AI tools, and rising competition from other South Asian markets, said Ashok Swain, general manager, DIA India.

- Nandita Vijayasimha, Bengaluru

By leveraging platforms like the DIA Medical Writing Conference which is underway in Bengaluru from July 11 and 12, participants can stay ahead in this evolving field, he added.

Medical writing industry's compound annual growth rate (CAGR) is estimated at over 12% for 2024-2030. The market is projected to reach US$ 750 million by 2030. Although the US remains the largest globally, India is currently the fastest-growing market. This momentum is being driven by the increasing presence of global pharma companies like Novartis, GSK, Lilly, Novo Nordisk, BMS, and Sanofi, all of whom have expanded their medical writing teams within India’s Global Capability Centers (GCCs). Many others are actively building or ramping up their capabilities in the region, he said.